Literature DB >> 24220583

The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells.

Chunhong Gu1, Joelle Gonzalez, Tong Zhang, Suzanne Kamel-Reid, Richard A Wells.   

Abstract

We observed AML cell lines vary in their sensitivity to induction of apoptosis by troglitazone (TG), which induces apoptosis through the generation of intracellular reactive oxygen species (ROS). TG-resistant cell lines had increased abundance of ARNT transcripts and protein. Expression of ARNT in TG-sensitive cells made these cells resistant to both TG and daunorubicin. ARNT-expressing cells had increased expression of SOD2 and Nrf2 transcripts and elevated intracellular GSH concentration. Our results indicate that ARNT expression in AML cells augments antioxidant response and confers resistance to ROS inducers. This suggests ARNT may modulate ROS signaling and drug response in AML.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ARNT; Chemoresistance; Hypoxia-inducible factor; Oxidative stress; Reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 24220583     DOI: 10.1016/j.leukres.2013.10.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies.

Authors:  Amy M Cooper; Curtis A Nutter; Muge N Kuyumcu-Martinez; Casey W Wright
Journal:  Mol Cell Biol       Date:  2022-04-11       Impact factor: 5.069

2.  Drug metabolism and clearance system in tumor cells of patients with multiple myeloma.

Authors:  Wafa Hassen; Alboukadel Kassambara; Thierry Reme; Surinder Sahota; Anja Seckinger; Laure Vincent; Guillaume Cartron; Jérôme Moreaux; Dirk Hose; Bernard Klein
Journal:  Oncotarget       Date:  2015-03-20

3.  Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer.

Authors:  Ying Wang; Kaichun Wu; Zhiping Yang; Qingchuan Zhao; Dongmei Fan; Po Xu; Yongzhan Nie; Daiming Fan
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

4.  An increase in reactive oxygen species by deregulation of ARNT enhances chemotherapeutic drug-induced cancer cell death.

Authors:  Jiunn-Min Shieh; Chih-Jie Shen; Wei-Chiao Chang; Hung-Chi Cheng; Ya-Yi Chan; Wan-Chen Huang; Wen-Chang Chang; Ben-Kuen Chen
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

5.  Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity.

Authors:  Kacie A Gardella; Israel Muro; Gloria Fang; Krishnakali Sarkar; Omayra Mendez; Casey W Wright
Journal:  Oncotarget       Date:  2016-03-08

Review 6.  Insights into the Dichotomous Regulation of SOD2 in Cancer.

Authors:  Yeon Soo Kim; Piyushi Gupta Vallur; Rébécca Phaëton; Karthikeyan Mythreye; Nadine Hempel
Journal:  Antioxidants (Basel)       Date:  2017-11-03

7.  Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.

Authors:  Renata Colla; Alberto Izzotti; Chiara De Ciucis; Daniela Fenoglio; Silvia Ravera; Andrea Speciale; Roberta Ricciarelli; Anna Lisa Furfaro; Alessandra Pulliero; Mario Passalacqua; Nicola Traverso; Maria Adelaide Pronzato; Cinzia Domenicotti; Barbara Marengo
Journal:  Oncotarget       Date:  2016-10-25

8.  Endothelial Aryl Hydrocarbon Receptor Nuclear Translocator Mediates the Angiogenic Response to Peripheral Ischemia in Mice With Type 2 Diabetes Mellitus.

Authors:  Tu Nguyen; Mei Zheng; Maura Knapp; Nikola Sladojevic; Qin Zhang; Lizhuo Ai; Devin Harrison; Anna Chen; Albert Sitikov; Le Shen; Frank J Gonzalez; Qiong Zhao; Yun Fang; James J K Liao; Rongxue Wu
Journal:  Front Cell Dev Biol       Date:  2021-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.